Last updated on December 2019

Observational Study of Blinatumomab

Brief description of study

An observational study of blinatumomab safety and effectiveness, utilisation, and treatment practices

Detailed Study Description

The primary objective of this study is to characterize the safety of Blincyto in routine clinical practice. Blincyto effectiveness, medication errors, and utilisation; and select healthcare resource use while using Blincyto will also be described. Safety and effectiveness of Blincyto in specified subgroups of patients will also be assessed.

Clinical Study Identifier: NCT03117621

Find a site near you

Start Over

Research Site

Helsinki, Finland
  Connect »